Integrative Oncology Program, The Oncology Service, Lin, Carmel & Zebulun Medical Centers, Clalit Health Services, Haifa, Western Galilee District, Israel.
Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel and Clalit Health Services, Haifa, Western Galilee District, Israel.
Curr Oncol Rep. 2023 Jun;25(6):559-568. doi: 10.1007/s11912-023-01359-8. Epub 2023 Mar 20.
Integrative oncology (IO) services provide a wide range of complementary medicine therapies, many of which can augment the beneficial effects of conventional supportive and palliative care for patients with ovarian cancer. This study aims to assess the current state of integrative oncology research in ovarian cancer care.
We review the clinical research both supporting the effectiveness of leading IO modalities in ovarian cancer care as well as addressing potential safety-related concerns. There is growing amount of clinical research supporting the use of IO and implementation of integrative gynecological oncology models of care within the conventional supportive cancer care setting. Additional research is still needed in order to create clinical guidelines for IO interventions for the treatment of female patients with ovarian cancer. These guidelines need to address both effectiveness and safety-related issues, providing oncology healthcare professionals with indications for which these patients can be referred to the IO treatment program.
综述目的:整合肿瘤学(IO)服务提供了广泛的补充医学疗法,其中许多疗法可以增强常规支持性和姑息性护理对卵巢癌患者的有益作用。本研究旨在评估当前卵巢癌治疗中整合肿瘤学研究的现状。
最近发现:我们回顾了支持 IO 模式在卵巢癌治疗中的有效性的临床研究,以及解决潜在的与安全性相关的问题。越来越多的临床研究支持在常规支持性癌症护理环境中使用 IO 并实施整合妇科肿瘤学护理模式。为了为女性卵巢癌患者的 IO 干预措施制定临床指南,还需要进行更多的研究。这些指南需要解决有效性和安全性相关问题,为肿瘤学医疗保健专业人员提供哪些患者可以转介到 IO 治疗计划的指示。